Current Liabilities
Derivative liabilities
Medtronic Derivative liabilities increased by 304.2% to $97M in Q1 2025 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ1 2015
Last reportedQ1 2025Feb 24, 2026
Metric ID:
fin_derivative_liabilitiesHistorical Data
6 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q3 '23 | Q1 '25 | |
|---|---|---|---|---|---|---|
| Value | $61M | $20M | $20M | $18M | $24M | $97M |
| QoQ Change | — | -67.2% | +0.0% | -10.0% | +33.3% | +304.2% |
| YoY Change | — | — | — | — | +33.3% | — |
Range$18M – $97M
CAGR+44.9%
Avg YoY Growth+33.3%
Median YoY Growth+33.3%
Current Streak2 quarters growth
Derivative liabilities at Other Companies
Frequently Asked Questions
- What is Medtronic's derivative liabilities?
- Medtronic (MDT) reported derivative liabilities of $97M in Q1 2025.